Union européenne - français - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - autres médicaments du système nerveux - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Union européenne - français - EMA (European Medicines Agency)

ptc therapeutics international limited - eladocagene exuparvovec - métabolisme des acides aminés, erreurs innées - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, ureum - crème - halcinonidum 1 mg, ureum 50 mg, antiox.: e 320, conserv.: triclosanum, chlorhexidini dihydrochloridum, excipiens ad pommade pour 1 g de la. - non infectés, les dermatoses inflammatoires - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, ureum - fettcrème - halcinonidum 1 mg, ureum 100 mg, conserv.: triclosanum, chlorhexidini dihydrochloridum, excipiens ad pommade pour 1 g de la. - non infectés, les dermatoses inflammatoires - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, salicylicium salicylicum - solution - halcinonidum 1 mg, acide salicylicum 20 mg, l'alcool isopropylicus, antiox.: e 320, excipiens ad solution de 1 ml. - non infectés, la maladie inflammatoire de hyperkeratotische et les dermatoses squameuses de parties du corps d'un poilu - synthetika